Merck MRK announced that the FDA has approved its blockbuster PD-L1 inhibitor, Keytruda (pembrolizumab), and its subcutaneous ...

Arbutus (ABUS) looks stronger after Moderna validates its LNP patents, with imdusiran showing durable viral control and a ...

Women who use Depo-Provera or other hormonal birth control pills face a higher risk of developing a slow-growing rare brain ...

Pfizer is undervalued, trading just over 8x 2026 earnings, with improving dividend yield and core business fundamentals.

So far, Pfizer has been an also-ran in the GLP-1 race, but that could change if its long-acting weight-loss medication takes ...

Both McDonald's and Pfizer are blue-chip laggards trading at a discount, both cut reliable dividend checks, and both promise ...

When two steel columns buckled this week inside the former Pfizer headquarters in midtown Manhattan, the scare prompted ...

The increasingly more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again. | The ...

Efforts to shore up the former Pfizer headquarters on the East Side of Manhattan continued Thursday after concerns of a ...

Two concurrent emergencies have captured the attention of New Yorkers: a Legionnaires’ outbreak on the Upper East Side and a ...

Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to ...

In the open-label study, DMD patients received Satellos’ oral drug for an additional 11 months, following an earlier 28-day trial.